z-logo
open-access-imgOpen Access
Effect of Hydrocortisone on Development of Shock Among Patients With Severe Sepsis
Author(s) -
Didier Keh,
Evelyn Trips,
Gernot Marx,
Stefan P. Wirtz,
Emad Abduljawwad,
Sven Bercker,
Holger Bogatsch,
Josef Briegel,
Christoph Engel,
Herwig Gerlach,
Anton Goldmann,
SvenOlaf Kuhn,
Lars Hüter,
Andreas MeierHellmann,
Axel Nierhaus,
Stefan Kluge,
Josefa Lehmke,
Markus Loeffler,
Michael Oppert,
Kerstin Resener,
Dirk Schädler,
Tobias Schuerholz,
Philipp Simon,
Norbert Weiler,
A. Weyland,
Konrad Reinhart,
Frank M. Brunkhorst
Publication year - 2016
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.2016.14799
Subject(s) - medicine , septic shock , sepsis , hydrocortisone , shock (circulatory) , surviving sepsis campaign , intensive care unit , weaning , placebo , intensive care , population , gastroenterology , anesthesia , surgery , intensive care medicine , severe sepsis , alternative medicine , environmental health , pathology
Adjunctive hydrocortisone therapy is suggested by the Surviving Sepsis Campaign in refractory septic shock only. The efficacy of hydrocortisone in patients with severe sepsis without shock remains controversial.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom